Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5008329 | 1.00 | L3MBTL1 (0.37) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA | |
| SCHEMBL16467167 | 0.75 | CYP19A1 (0.45) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA | |
| SCHEMBL28112247 | 0.74 | CYP19A1 (0.41) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA | |
| SCHEMBL16467209 | 0.73 | CYP19A1 (0.43) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA | |
| SCHEMBL12704999 | 0.69 | EPHX1 (0.45) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA | |
| SCHEMBL12705000 | 0.69 | EPHX1 (0.45) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA | |
| SCHEMBL11991797 | 0.69 | EPHX1 (0.45) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA | |
| SCHEMBL21396853 | 0.69 | L3MBTL1 (0.38) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA | |
| SCHEMBL14748194 | 0.69 | EPHX1 (0.41) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA | |
| SCHEMBL14422659 | 0.68 | EPHX1 (0.48) | L3MBTL1EPHX1CYP19A1CYP2C19NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1637514-B1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ACRYLATE | TOSOH F TECH INC (JP) | 2014-05-07 | — | — | EP | disclosed |
| EP-1637514-B1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ACRYLATE | TOSOH F TECH INC (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-7470808-B2 | Method for producing fluorine-containing acrylate | TOSOH F-TECH, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-7470808-B2 | Method for producing fluorine-containing acrylate | TOSOH F-TECH, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-7470808-B2 | Method for producing fluorine-containing acrylate | TOSOH F-TECH, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-20060122423-A1 | Method for producing fluorine-containing acrylate | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1637514-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ACRYLATE | Tosoh F-Tech, Inc. (JP) | 2006-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122423-A1 | Method for producing fluorine-containing acrylate | AFF4, CBR1, AFF1 | L3MBTL1 3198/4885EPHX1 1064/4885CYP19A1 1190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.